Robert H Lurie Cancer Center
Robert H Lurie Cancer Center
Chicago, Illinois, United States2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, high grade B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, non-Hodgkin lymphoma, primary central nervous system lymphoma | Recruiting | Not stated | 2026-08-05 | NCT06116110 | |
| DALY II USA/ MB-CART2019.1 for DLBCL | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Richter transformation, central nervous system cancer, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mantle cell lymphoma, neoplasm, nervous system disorder, primary central nervous system lymphoma | Recruiting | Phase 2 | 2026-07-13 | NCT04792489 |